TPG, Lyft, and GeneDX announced deals; Onsemi, meanwhile, ended discussions after offering its target $35.10 per share.

The company's bankruptcy has spotlighted the vulnerability of private consumer genetic testing data.

Me, the DNA-testing firm that filed for bankruptcy protection in March, is under investigation by the House Committee on Energy and Commerce over concerns related to the sale of its genetic data.

The US Justice Department said Thursday it may review a potential sale of 23andMe users’ genetic data for potential national ...

On March 23, 2025, 23andMe, along with its affiliates, filed for voluntary Chapter 11 bankruptcy. The company’s decision to file for ...

Me has filed for bankruptcy as is seeking buyers. Here's what could happen to the company's DNA database, one of the largest ...

Since its 2006 founding, 23andMe’s (the “Company”) service of collecting, analyzing, and reporting customers’ genetic ...

Anne Wojcicki dreamed of a revolution in personal genomics and medicine. She set up 23andMe to realise her vision in 2006.

Ava Labs exec John Nahas says decentralization is about more than privacy — it’s a shift in power, giving individuals control ...

Have you ever wondered about your genetic ancestry or familial health risks? Or perhaps needed legal proof of biological ...